Polymorphisms in the 11beta-hydroxysteroid dehydrogenase type 1 gene associate with low bone mineral density: A role for autocrine glucocorticoid metabolism in bone physiology

被引：0
|
作者：
Cooper, MS
Draper, N
Duncan, EL
Wass, JAH
Shepperd, MC
Hewison, M
Stewart, PM
机构：
[1] Univ Birmingham, Div Med Sci, Birmingham B15 2TT, W Midlands, England
[2] Wellcome Trust Ctr Human Genet, Oxford, England
[3] Nuffield Orthopaed Ctr, Dept Endocrinol, Oxford OX3 7LD, England
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2001年 / 16卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P4
引用
收藏
页码：1181 / 1181
页数：1
相关论文
共 50 条
  • [1] 11beta-hydroxysteroid dehydrogenase type 1 activity determines the effects of glucocorticoids on bone
    Cooper, MS
    Blumsohn, A
    Goddard, PE
    Bartlett, WA
    Eastell, R
    Hewison, M
    Stewart, PM
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (07) : 1330 - 1330
  • [2] 11 beta-Hydroxysteroid dehydrogenase type 1 and bone
    Cooper, M. S.
    OSTEOLOGIE, 2016, 25 (04) : 256 - 261
  • [3] The impact of endogenous cortisone on bone: Demonstration of in vivo 11beta-hydroxysteroid dehydrogenase type 1 activity.
    Cooper, MS
    Syddall, HE
    Wood, PJ
    Stewart, PM
    Cooper, C
    Dennison, EM
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S304 - S305
  • [4] Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1: Induction by glucocorticoids and metabolism of prednisone/prednisolone
    Cooper, MS
    Rabbitt, EH
    Goddard, P
    Bartlett, W
    Hewison, M
    Stewart, PM
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (06) : 1180 - 1180
  • [5] Glucocorticoid activation by 11beta-hydroxysteroid dehydrogenase type 1:: A novel pharmacological target in the metabolic syndrome
    Oppermann, U
    Hult, M
    Shafqat, N
    Elleby, B
    Svensson, S
    Vallgårda, J
    Abrahmsen, L
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 : R13 - R13
  • [6] Polymorphisms in the promoter of the human 11beta-hydroxysteroid dehydrogenase type 2 (11B-HSD2) gene
    Alikhani-Koupaei, R.
    Fouladkou, F.
    Fustier, F.
    Cenni, B.
    Sharma, A. M.
    Deter, H. C.
    Frey, B. M.
    Frey, F. J.
    CLINICAL BIOCHEMISTRY, 2008, 41 (03) : 186 - 186
  • [7] Genetic Polymorphisms in 11β-Hydroxysteroid Dehydrogenase Type 1 Correlate With the Postdexamethasone Cortisol Levels and Bone Mineral Density in Patients Evaluated for Osteoporosis
    Siggelkow, Heide
    Etmanski, Michael
    Bozkurt, Sarayi
    Gross, Parissa
    Koepp, Regine
    Brockmoeller, Juergen
    Tzvetkov, Mladen V.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (02): : E293 - E302
  • [8] The enzyme 11?-hydroxysteroid-dehydrogenase influences bone metabolism and bone mineral density through local inactivation of prednisolone
    Blaschke, Martina
    Dressel, Ina
    Koepp, Regine
    Armbrecht, Gabriele
    Sehmisch, Stephan
    Tzvektov, Mlladen
    Streit, Frank
    Reichardt, Holger M.
    Glueer, Claus-C
    Siggelkow, Heide
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 420 - 420
  • [9] 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 REGULATES THE SUPPRESSION OF INFLAMMATION, JOINT DESTRUCTION AND SYSTEMIC BONE LOSS IN A MODEL OF CHRONIC INFLAMMATION
    Hardy, Rowan S.
    Fenton, Chloe
    Naylor, Amy
    Croft, Adam
    Lavery, Gareth
    Buckley, Christopher
    Cooper, Mark
    Raza, Karim
    RHEUMATOLOGY, 2018, 57
  • [10] Identification of polymorphisms in the human 11beta-hydroxysteroid dehydrogenase type 2 gene promoter: functional characterization and relevance for salt sensitivity
    Alikhani-Koupaei, Rasoul
    Fouladkou, Fatemeh
    Fustier, Pierre
    Cenni, Bruno
    Sharma, Arya M.
    Deter, Hans-Christian
    Frey, Brigitte M.
    Frey, Felix J.
    FASEB JOURNAL, 2007, 21 (13): : 3618 - 3628
12345